A protocol for characterization of extremely preterm infant gut microbiota in double-blind clinical trials
2021 (English)In: STAR Protocols, E-ISSN 2666-1667, Vol. 2, no 3, article id 100652Article in journal (Refereed) Published
Abstract [en]
16S rRNA gene sequencing enables microbial community profiling, but recovering fecal DNA from extremely premature infants is challenging. Here, we describe an optimized protocol for fecal DNA isolation, library preparation for 16S rRNA gene sequencing, taxonomy assignation, and statistical analyses. The protocol is complemented with a quantitative PCR for probiotic L. reuteri identification. This protocol describes how to characterize preterm infant gut microbiota and relate it to probiotic supplementation and clinical outcomes. It is customizable for other clinical trials. For complete details on the use and execution of this protocol, please refer to Martí et al. (2021) and Spreckels et al. (2021).
Place, publisher, year, edition, pages
Cambridge, MA, United States: Cell press , 2021. Vol. 2, no 3, article id 100652
Keywords [en]
Clinical Protocol; Health Sciences; Microbiology; Molecular Biology; Sequencing
National Category
Microbiology in the medical area
Identifiers
URN: urn:nbn:se:liu:diva-183530DOI: 10.1016/j.xpro.2021.100652ISI: 001049298400006PubMedID: 34308378Scopus ID: 2-s2.0-85109457709OAI: oai:DiVA.org:liu-183530DiVA, id: diva2:1643855
Note
Funding: the Lions Forskningsfond mot folksjukdomar (Lions LiU-2019-03041), the Swedish Research Council (grant number 921.2014-7060), the Swedish Society for Medical Research, the Swedish Society of Medicine, the Research Council for South-East Sweden, ALF Grants, Region Östergötland, and BioGaia AB, Stockholm, Sweden.
2022-03-112022-03-112025-08-28Bibliographically approved